Jane Street Group, LLC Neuro Pace Inc Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.78 - $17.5 $344,167 - $615,842	35,191 Added 95.57%	72,013 $950,000
Q4 2023 Feb 14, 2024	BUY	$5.9 - $10.31 $217,249 - $379,634	36,822 New	36,822 $379,000
Q3 2021 Nov 16, 2021	SELL	$15.85 - $25.07 $143,236 - $226,557	-9,037 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.03 - $26.5 $171,974 - $239,480	9,037 New	9,037 $215,000

21.3M

1.3K

100

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $278M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.